Data / Form D filings / HLS Therapeutics Inc.
HLS Therapeutics Inc.: Form D filings
HLS Therapeutics Inc., a pharmaceuticals company in Caledon, Ontario, Canada, filed 2 Form D notices with the SEC in 2015. The latest, on August 26, 2015, reports $30 million sold of a $30 million offering to 4 investors.
Find out what HLS Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17474 HUMBER STATION ROAD, Caledon, Ontario, Canada, L7E 0
- Phone
- (416) 624-6568
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1648315
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2015 | New notice | $30,000,000 | $30,000,000 | $0 | 4 | Aug 11, 2015 | sec.gov |
| Jul 17, 2015 | New notice | $112,787,710 | $112,787,710 | $0 | 22 | Jul 2, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bill D Wells | Director | |
| Gilbert D Godin | Executive Officer, Director | |
| Chris D Fibiger | Executive Officer | |
| Joseph D MacLean | Executive Officer, Director | |
| Gregory D Gubitz | Executive Officer, Director, Promoter |
Every Form D from the week of Aug 24, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HLS Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.